Claims for Patent: 5,908,838
✉ Email this page to a colleague
Summary for Patent: 5,908,838
Title: | Method for the treatment of acne |
Abstract: | A method for the treatment of acne is provided which results in the reduction of vestibular side effects following administration of oral tetracycline antibiotics. |
Inventor(s): | Gans; Eugene H. (Phoenix, AZ) |
Assignee: | Medics Pharmaceutical Corporation (Phoenix, AZ) |
Application Number: | 09/028,871 |
Patent Claims: |
1. A method for reducing the incidence or severity of vestibular side effects resulting from the treatment of acne by the use of oral tetracycline antibiotics, comprising administering
the oral tetracycline antibiotic in a slowly dissolving dosage form.
2. The method of claim 1, wherein the oral tetracycline antibiotic is minocycline. 3. The method of claim 2, wherein the antibiotic dissolves at a rate no faster than 15 percent in 15 minutes, 35 percent in 30 minutes, 50 percent in 45 minutes and 80 percent in 60 minutes. 4. The method of the claim 2 wherein the antibiotic dissolves at a rate no faster than 20 percent in 15 minutes, 50 percent in 30 minutes, and 75 percent in 45 minutes. 5. The method of claim 2 wherein and the antibiotic dissolves at a rate no faster than 30 percent in 15 minutes, 60 percent in 30 minutes, and 75 percent in 45 minutes. 6. The method of the claim 2 wherein the antibiotic dissolves at a rate no faster than 35 percent in 15 minutes, 80 percent in 30 minutes, and one hundred percent in 45 minutes. 7. The method of claim 2, wherein the antibiotic dissolves at a rate within the range of 20 to 40 percent in 15 minutes, 50 to 80 percent in 30 minutes, 70 to 95 percent in 45 minutes and 95 to 100 percent in 60 minutes. 8. The method of the claim 2 wherein the antibiotic dissolves at a rate within the range of 25 to 35 percent in 15 minutes, 60 to 80 percent in 30 minutes, and 80 to 100 percent in 45 minutes. 9. The method of claim 2 wherein and the antibiotic dissolves at a rate within the range of 30 to 35 percent in 15 minutes, 65 to 75 percent in 30 minutes, and 90 to 100 percent in 45 minutes. 10. A method for reducing the incidence or severity of vestibular side effects resulting from the treatment of acne by the use of oral tetracycline antibiotics, comprising administering the oral tetracycline antibiotic in a slowly dissolving dosage form, wherein the dissolution of the antibiotic is substantially complete in less than 24 hours. 11. The method of claim 10, wherein the oral tetracycline antibiotic is minocycline. 12. The method of claim 11, wherein the antibiotic dissolves at a rate no faster than 15 percent in 15 minutes, 35 percent in 30 minutes, 50 percent in 45 minutes and 80 percent in 60 minutes. 13. The method of the claim 11 wherein the antibiotic dissolves at a rate no faster than 20 percent in 15 minutes, 50 percent in 30 minutes, and 75 percent in 45 minutes. 14. The method of claim 11 wherein and the antibiotic dissolves at a rate no faster than 30 percent in 15 minutes, 60 percent in 30 minutes, and 75 percent in 45 minutes. 15. The method of the claim 11 wherein the antibiotic dissolves at a rate no faster than 35 percent in 15 minutes, 80 percent in 30 minutes, and one hundred percent in 45 minutes. 16. The method of claim 11, wherein the antibiotic dissolves at a rate within the range of 20 to 40 percent in 15 minutes, 50 to 80 percent in 30 minutes, 70 to 95 percent in 45 minutes and 95 to 100 percent in 60 minutes. 17. The method of the claim 11 wherein the antibiotic dissolves at a rate within the range of 25 to 35 percent in 15 minutes, 60 to 80 percent in 30 minutes, and 80 to 100 percent in 45 minutes. 18. The method of claim 11 wherein and the antibiotic dissolves at a rate within the range of 30 to 35 percent in 15 minutes, 65 to 75 percent in 30 minutes, and 90 to 100 percent in 45 minutes. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.